Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

NCT ID: NCT03991728

Last Updated: 2025-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-15

Study Completion Date

2033-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective data will be collected in approximately 200 patients treated with an TMJ replacement. Patients will be followed up according to the standard (routine) for up to 5 years after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s and anticipated or procedure-related adverse events (i.e. complications).

This registry is designed to be able to assess the number of patients who refuse alloplastic total TMJ replacement. Therefore, the participating sites are asked to register all cases of refused TMJ replacements too.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More in detail this registry has the following objectives:

* To describe clinical indications for TMJ replacement, and treatment patterns (including differences among regions if feasible)
* To describe the clinical evolution and outcomes of patients treated with a TMJ replacement
* To explore the relationship(s) between treatment, outcome(s) and quality of life (QoL).
* To identify predictive factors for favorable outcomes (pain reduction, range of motion (ROM), occlusal status, QoL) in patients treated with TMJ replacement.
* To describe the reasons of patients who refused TMJ replacements

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Joint Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alloplastic total TMJ replacement

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics. The registry does not dictate any specific treatment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years and or older
* Patients requiring alloplastic total TMJ replacement
* Informed consent obtained, i.e.:

* Ability to understand the content of the patient information/informed consent form (ICF)
* Willingness and ability to participate in the registry according to the Registry Plan (RP)
* Signed and dated ethics committee (EC) / Institutional review board (IRB) approved written informed consent

Exclusion Criteria

* Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy or women planning to conceive within the study period
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Innovation Translation Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andreas Thor, MD

Role: PRINCIPAL_INVESTIGATOR

Oral and Maxillofacial surgery Uppsala University Hospital

Vinay V Kumar, MD

Role: PRINCIPAL_INVESTIGATOR

Oral and Maxillofacial surgery Uppsala University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital BP - A Beneficência Portuguesa de São Paulo

São Paulo, , Brazil

Site Status RECRUITING

Estetica Maxilofacial

Bogotá, , Colombia

Site Status SUSPENDED

Rigshospitalet

Copenhagen, , Denmark

Site Status RECRUITING

Hannover Medical School

Hanover, , Germany

Site Status RECRUITING

University Hospital Leipzig

Leipzig, , Germany

Site Status RECRUITING

Klinikum der Johannes Gutenberg Universität Mainz

Mainz, , Germany

Site Status NOT_YET_RECRUITING

Klinikum der LMU München

Munich, , Germany

Site Status RECRUITING

Sri Shankara Cancer Hospital and Research Center

Bangalore, , India

Site Status RECRUITING

All India Institute of Medical Sciences (AIIMS)

New Delhi, , India

Site Status TERMINATED

Erasmus Medisch Centrum

Rotterdam, , Netherlands

Site Status RECRUITING

Waikato DHB

Christchurch, , New Zealand

Site Status TERMINATED

Hutt Hospital

Lower Hutt, , New Zealand

Site Status SUSPENDED

Mayo Hospital

Lahore, , Pakistan

Site Status TERMINATED

Wojewódzki Specjalistyczny Szpital Dziecięcy

Olsztyn, , Poland

Site Status RECRUITING

National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Healthcare of the Russian Federation

Moscow, , Russia

Site Status RECRUITING

Clinic for Maxillofacial Surgery, University of Belgrade

Belgrade, , Serbia

Site Status RECRUITING

King Edward VIII Hospital

Durban, , South Africa

Site Status RECRUITING

12 de Octubre University Hospital

Madrid, , Spain

Site Status RECRUITING

Falu Hospital

Falun, , Sweden

Site Status RECRUITING

Skåne University Hospital

Lund, , Sweden

Site Status RECRUITING

Karolinska University Hospital

Stockholm, , Sweden

Site Status RECRUITING

Uppsala University Hospital

Uppsala, , Sweden

Site Status RECRUITING

Universitätsspital Basel

Basel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil Colombia Denmark Germany India Netherlands New Zealand Pakistan Poland Russia Serbia South Africa Spain Sweden Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Viola Grünenfelder

Role: CONTACT

+41 79 696 33 97

Aleksandra Hodor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gabriel Pastore, MD

Role: primary

Johanna Nilsson, MD

Role: primary

Philippe Korn, MD

Role: primary

Rüdiger Zimmerer, MD

Role: primary

+49341-97204443

Daniel Thiem

Role: primary

Wenko Smolka, MD

Role: primary

Vinay V Kumar, MD

Role: primary

Eppo Wolvius, MD

Role: primary

Krzysztof Dowgierd, MD

Role: primary

+48 89 539 32 61

Sergey Epifanov, MD

Role: primary

Drago Jelovac, MD

Role: primary

+381112685268

Vivesh Rughubar, MD

Role: primary

Ignacio Zubillaga, MD

Role: primary

Jani Talvilahti, MD

Role: primary

Martin Bengtsson, MD

Role: primary

Mattias Ulmner, MD

Role: primary

Andreas Thor, MD

Role: primary

+46 (0)18 611 6450

Florian Thieringer, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TMJ Replacement

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immediate Versus Late Placement
NCT04741607 RECRUITING NA
Immediate Loading in Single Tooth Implants
NCT05409287 ACTIVE_NOT_RECRUITING NA